We are live on
!
Find out more
Invesco Pharmaceuticals ETF
PJP
PJP
88 hedge funds and large institutions have $61.3M invested in Invesco Pharmaceuticals ETF in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 19 increasing their positions, 24 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
88% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 8
7% more funds holding
Funds holding: 82 → 88 (+6)
2.57% more ownership
Funds ownership: 14.78% → 17.35% (+2.6%)
5% less capital invested
Capital invested by funds: $64.8M → $61.3M (-$3.48M)
21% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 24
Holders
88
Holders Change
+6
Holders Change %
+7.32%
% of All Funds
1.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
19
Reduced
24
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Wells Fargo
San Francisco,
California
|
-$2.28M |
| 2 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$1.33M |
| 3 |
Citigroup
New York
|
-$517K |
| 4 |
FTUS
Flow Traders U.S.
New York
|
-$469K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$246K |
